Guardian Pharmacy Services, Inc. (GRDN) Market Cap & Valuation Ratios
Guardian Pharmacy Services, Inc. (GRDN) has a market cap of $2.5B, a trailing P/E of 38.7 and a price-to-sales ratio of 1.7, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
GRDNGuardian Pharmacy Services, Inc.Follow GRDN — free
—
Price chart with a free account
- Market cap
- 2.5B
- P/E TTM
- 38.7
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 17 Nov, in 24 days
Peers
medical care facilities · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| GRDN | 2.5 | 38.7 | 1.6 | 22.1 | 3.0% | +10% | 6% | 38% |
| ACHC | 2.9 | — | 1.5 | — | -4.6% | +4% | -28% | -20% |
| AVAH | 2.9 | — | 1.6 | 15.0 | 5.4% | +20% | 11% | 13% |
| BKD | 2.4 | — | 2.1 | 14.5 | 0.0% | -4% | 3% | 2% |
| MD | 2.4 | 14.0 | 1.3 | 10.7 | 9.6% | +0.5% | 11% | 14% |
| ADUS | 2.3 | 21.3 | 1.5 | 13.6 | 6.8% | +16% | 10% | 10% |
| ASTH | 2.1 | 45.1 | 0.7 | 16.0 | 4.5% | +59% | 3% | 6% |
| SGRY | 2.1 | — | 1.7 | 10.0 | 9.1% | +4% | 11% | 6% |
| AMN | 1.9 | 17.8 | 0.7 | 6.5 | 23.6% | +24% | 6% | 10% |
| ARDT | 1.7 | 22.3 | 0.3 | 5.7 | 17.6% | +3% | 3% | 9% |
| HCSG | 1.7 | 17.1 | 0.8 | 10.6 | 6.3% | +4% | 7% | 28% |
| Median of these 10 | 19.6 | 1.4 | 10.7 | 6.5% | +4% | 6% | 10% |
P/E 38.7 vs. a peer median of 19.6; EV/Sales 1.6 vs. 1.4.
Growth vs. price
each dot a company · hover or tap for valuesACHC and AVAH and BKD and SGRY have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
Guardian Pharmacy Services, Inc. — questions
- What is Guardian Pharmacy Services, Inc.'s market cap?
- $2.5B.
- What is Guardian Pharmacy Services, Inc.'s P/E ratio?
- 38.7 on trailing twelve-month earnings to 2026-06-30.
- What is Guardian Pharmacy Services, Inc.'s price-to-sales ratio?
- 1.7.
Every figure on this page comes from Guardian Pharmacy Services, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.